8-KShareholder Matters

CARDINAL HEALTH INC 8-K Report, Shareholder Vote Results (Nov 13, 2017)

Filed November 13, 2017For Securities:CAH

Summary

This 8-K filing from Cardinal Health Inc. (CAH) details the results of its 2017 Annual Meeting of Shareholders held on November 8, 2017. The primary focus of the report is the outcome of shareholder votes on six key proposals. Most notably, all eleven director nominees were elected to the board, and the appointment of Ernst & Young LLP as the independent auditor for the upcoming fiscal year was ratified. Additionally, shareholders approved the executive compensation on an advisory basis (say-on-pay) and voted in favor of holding these advisory votes annually. However, a significant shareholder proposal urging the adoption of a policy for an independent Board Chairman was not approved. Another shareholder proposal concerning management's access to vote tallies for executive pay matters was not voted upon as it was not presented by a shareholder representative at the meeting. This filing provides investors with insight into shareholder sentiment on corporate governance and executive compensation.

Key Highlights

  • 1All eleven director nominees were elected to the Cardinal Health, Inc. Board of Directors for a term until the 2018 Annual Meeting.
  • 2Shareholders ratified the appointment of Ernst & Young LLP as the Company's independent auditor for the fiscal year ending June 30, 2018.
  • 3The advisory 'say-on-pay' vote, approving the compensation of named executive officers, passed with a significant majority.
  • 4Shareholders overwhelmingly supported holding future advisory votes on executive compensation on an annual basis.
  • 5A shareholder proposal to implement a policy requiring an independent Board Chairman was not approved by shareholders.
  • 6A second shareholder proposal related to management's access to vote tallies on executive pay matters was not voted upon as it was not formally presented at the meeting.

Frequently Asked Questions

The key outcomes include the election of all director nominees, ratification of the independent auditor (Ernst & Young LLP), approval of executive compensation on an advisory basis (say-on-pay), and a decision to hold annual say-on-pay votes. However, a proposal for an independent Board Chairman was not approved.

Shareholders approved the named executive officers' compensation on an advisory basis ('say-on-pay'). They also voted in favor of holding these advisory votes annually. While the overall compensation was approved, the significant number of 'against' votes and broker non-votes in the say-on-pay proposal suggests some level of shareholder scrutiny or disagreement.

The shareholder proposal urging the Board to adopt a policy that the Chairman of the Board be an independent director was not approved by the shareholders. The 'against' votes significantly outnumbered the 'for' votes.

Based on shareholder support, the Board has committed to holding advisory votes on executive compensation annually until at least the company's 2023 Annual Meeting of Shareholders. This indicates a responsiveness to shareholder preference for regular engagement on executive pay.